Bone mineral density in institutionalised patients with refractory epilepsy

Seizure

Volumn 16, Issue 6, 2007, Pages 538-541

  Swanton, Josephine ^a   Simister, Robert ^a   Altmann, Daniel ^a,b   Watts, Hilary ^b   Keen, Richard ^c   Duncan, John S ^a   Koepp, Matthias J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Antiepileptic drugs; Bone mineral density; Osteoporosis

Indexed keywords

25 HYDROXYERGOCALCIFEROL; ACETAZOLAMIDE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PARATHYROID HORMONE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CHRONIC PATIENT; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EPILEPSY; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BODY COMPOSITION; BONE DENSITY; EPILEPSY; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED;

EID: 34547662176     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.03.003     Document Type: Article

References (10)

1. Persson H.B., Alberts K.A., Farahmand B.Y., and Tomson T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia 43 (2002) 768-772
2. Ali I.I., Schuh L., Barkley G.L., and Gates J.R. Antiepileptic drugs and reduce bone mineral density. Epilepsy Behav 5 (2004) 296-300
3. Farhat G., Yamout B., Mikati M.A., Demirjian S., Sawaya R., and El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58 (2002) 1348-1353
4. Sato Y., Kondo I., Ishida S., Motooka H., Takayama K., Tomita Y., et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57 (2001) 445-449
5. Ravn P., Alexandersen P., and Mollgaard A. Bone densitometry: a new, highly responsive region of interest in the distal forearm to monitor the effect of osteoporosis treatment. Osteoporos Int 9 (1999) 277-283
6. Kubota F., Kifune A., Shibata N., Akata T., Takeuchi K., Takahashi S., et al. Bone mineral density of epileptic patients on long term antiepileptic therapy: a quantitative digital radiographic study. Epilepsy Res 33 (1999) 93-97
7. Pierce W.M., Nardin G.F., Fuqua M.F., Sabah-Maren E., and Stern S.H. Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J Bone Miner Res 6 (1991) 347-354
8. Grampp S., Genant H.K., and Mathur A. Comparisons of non-invasive bone mineral measurements in assessing age-related bone loss, fracture discrimination and diagnostic classification. J Bone Miner Res 12 (1997) 697-711
9. Augat P., Fuerst T., and Genant H.K. Quantitative bone mineral assessment of the forearm: a review. Osteoporos Int 8 (1998) 299-310
10. Stephen L.J., McLellan A.R., Harrison J.H., Shapiro D., Dominiczak M.H., Sills G.J., et al. Bone density and antiepileptic drugs: a case controlled study. Seizure 8 (1999) 339-342